Health ❯Healthcare ❯Pharmaceuticals

Drug Development

Clinical Trials Alzheimer's Disease Novo Nordisk Obesity Treatments Weight Loss Drugs Eli Lilly Monoclonal Antibodies Obesity Treatment Combination Therapy HIV Prevention

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Data from the study are being readied for regulatory submission ahead of an August presentation at the European Society of Cardiology Congress.

Weekly Parkinson’s Injection Secures Patent After Successful Lab Trials

ProKidney Shares Climb Over 700% Ahead of FDA Meeting

Swissmedic Approves First Malaria Treatment for Newborns Under 4.5 kg

FDA Clears MT-125 for First Human Trials in Treatment-Resistant Glioblastoma

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection

FDA Approves Regeneron and Sanofi’s Dupixent for Bullous Pemphigoid

Eli Lilly to Acquire Verve Therapeutics as Gene-Editing Trial Begins

NHS England First Worldwide to Roll Out 'Trojan Horse' Myeloma Therapy

Families Face Postcode Lottery for NHS Access to Duchenne Drug Givinostat

Robinhood Excluded From June S&P 500 Rebalance Despite Doubling in Value

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

GPT-4 Identifies Existing Drug Combinations That Kill Breast Cancer Cells

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab